Literature DB >> 11902072

Transfemoral superior ophthalmic vein approach via the facial vein for the treatment of carotid-cavernous fistulas--two case reports.

Shinya Kohyama1, Tatsumi Kaji, Aya M Tokumaru, Shoichi Kusano, Shoichiro Ishihara, Katsuji Shima.   

Abstract

Two elderly female patients with carotid-cavernous fistulas (CCFs) were treated by transvenous embolization through a transfemoral superior ophthalmic vein approach via the facial vein. Complete occlusion of CCFs was not achieved with this technique exclusively, but the technique was effective in these cases. This technique provides an alternative to other transvenous approaches for the treatment of CCFs.

Entities:  

Mesh:

Year:  2002        PMID: 11902072     DOI: 10.2176/nmc.42.18

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Targeted compartmental embolization of cavernous sinus dural arteriovenous fistulae using transfemoral medial and lateral facial vein approaches.

Authors:  R Agid; R A Willinsky; C Haw; M P S Souza; I J Vanek; K G terBrugge
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

2.  Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management.

Authors:  D J Kim; D I Kim; S H Suh; J Kim; S K Lee; E Y Kim; T S Chung
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

3.  Transvenous embolization of dural carotid cavernous fistulas: a series of 44 consecutive patients.

Authors:  K Yoshida; M Melake; H Oishi; M Yamamoto; H Arai
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-03       Impact factor: 3.825

4.  Use of a Rigid-Tipped Microguidewire for the Endovascular Treatment of Cavernous Sinus Dural Arteriovenous Fistulas with an Occluded Inferior Petrosal Sinus.

Authors:  Mohamed Adel Deniwar; Boseong Kwon; Yunsun Song; Jung Cheol Park; Deok Hee Lee
Journal:  J Korean Neurosurg Soc       Date:  2022-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.